Calcium-activated chloride channels (CaCCs) are one of five families of chloride channels, ubiquitously expressed, and essential for a host of biological actions. CaCCs have key roles in processes as diverse as olfactory transduction and epithelial secretion, and also CaCCs are essential in smooth muscle contraction. The corpus cavernosum is a vascular smooth muscle that must relax to facilitate erections. Parasympathetic activation produces relaxation of the corpus cavernosum through a nitric oxidedependent pathway, and sympathetic stimulation in both preventing and terminating erections by contracting the corpus cavernosum. Both these pathways affect activity of CaCCs. The past 5 years produced many successes in CaCC research. One key area of success was the identification of the elusive 'molecular candidate' of CaCCs, as the TMEM16A protein (dubbed anoctamin-1) and potentially other members of the anoctamin family of transmembrane proteins. However, enthusiasm has been somewhat tempered because of evidence that this family of proteins may not be responsible for calcium-activated chloride currents in certain epithelial tissues. Several studies identified specific inhibitors of CaCCs as well as specific inhibitors for anoctamin-1. Despite the number of recent achievements in this field there are many details that still need to be elucidated. Of particular value would be more details on the identity of the CaCCs in corpus cavernosum smooth muscle, using new inhibitors to gain insight into the signalling pathway, and the evaluation of whether inhibition of CaCCs provides any specific benefit in different models of ED.
INTRODUCTION
Ion channels, most simply, are proteins that form pores in cell membranes that may permit the free passage of certain ions. These channels are broadly divided into those that selectively conduct positively charged ions and those that are selective for negatively charged ions. Channels involved in conducting ions with positive charges are logically termed 'cation channels' whereas, channels that conduct negative ions have come to be known as 'chloride channels', although it would be more accurate to define the negative ion pores as 'anion channels'. 'Chloride channels' is recognized as a doubly inaccurate name because these channels are not only permeable to many anions other than chloride but some 'chloride channels' are, in fact, not channels but antiporters facilitating anion movement. 1, 2 The misunderstanding of chloride channels has run deeper than a simple misnomer. For many years it was believed that chloride tended to be in electrochemical equilibrium across membranes and that chloride channels were of little consequence to any cellular or physiological processes. This misconception likely contributed to the relative dearth of chloride channel research conducted until the 1990s. 2 In the past two decades, however, significant inroads have been made toward understanding the different types, roles, mechanisms, structures and pharmacology of chloride channels.
FIVE FAMILIES OF CHLORIDE CHANNELS
New developments in the research of calcium-activated chloride channels (CaCCs) are relevant to sexual medicine. CaCCs have an important physiological role in contraction of the corpus cavernosum, an action that is necessary for the penis to remain flaccid. Inhibition of these channels thus holds promise as a therapeutic target for ED. In addition to CaCCs there are four other families of chloride channels: ligand-gated chloride channels, the cystic fibrosis transmembrane regulator (CFTR), ClC voltage-gated chloride channels and volume-regulated anion channels (Table 1) . These families are classified largely by homology and are diverse in function. 3 Members of the same family tend to share a common mechanism, but there are many cases where the pharmacology between multiple families can overlap.
chloride ions between neurons and smooth muscle cells. The presence of inhibitory hyperpolarizing chloride currents, and the ligand-activated nature of these currents was identified in the 1950s and 1960s. 4--6 The majority of the research into other families of chloride channels, however, was performed decades later.
In 1989, it was found that the mutation responsible for cystic fibrosis occurs in a gene encoding a chloride channel, and the CFTR channel was successfully cloned. 7--9 The efflux of anions controlled by this channel is very important for ionic and fluid homeostasis at epithelial membranes. 10 Research into cystic fibrosis, as well as research independent of cystic fibrosis in the years following this discovery helped make the 1990s a decade of considerable advances in the field of chloride channel research. These discoveries include many developments regarding three additional families of chloride channels.
ClC channels are a family of nine chloride channels and transporters---denoted as ClC-1 through to ClC-7, ClC-Ka and ClCKb---that are structurally similar, and are all voltage gated. 11 The nine members of this family found in mammals were initially identified based on homology to a widely studied chloride channel (now called ClC-0) responsible for developing preyshocking current in the electric ray Torpedo marmorata. 12, 13 Volume-regulated anion channels, also called swelling-activated chloride channels, are thought to function mainly in the regulation of cell volume in response to hypotonic solution by releasing anions to produce an osmotic efflux.
14 A member of the ClC family (ClC-3) has been proposed as the channel responsible for volumeactivated anion conductance, 15, 16 but this is a matter of some dispute. 3, 17 CaCCs were first discovered in the early 1980s because of their presence in large numbers in Xenopus oocytes. 18, 19 In oocytes, CaCCs open to depolarize the membrane with a chloride efflux, which prevents the entry of multiple sperm, but these channels perform a diverse array of functions in other tissues, including signal and sensory transduction, membrane depolarization, epithelial secretion and smooth muscle contraction. A review by Hartzell et al. 20 describes these various functions in detail, and also raises the possibility that there are as many as four different subtypes of CaCCs because of differences in certain physical properties---particularly conductance---between individual channels.
CACCS IN THE CORPUS CAVERNOSUM
It is the role of CaCCs in the contraction of the corpus cavernosum smooth muscle that is of particular interest to sexual medicine researchers. The presence of chloride currents activated by a rise in intracellular calcium in smooth muscle cells was established in 1987 by the current-clamp investigations of rat anococcygeus smooth muscle. 21, 22 In the decades following those early investigations, smooth muscle CaCCs in the corpus cavernosum were shown to respond to a number of different agonists (including norepinephrine, histamine and endothelin-1) all of which ultimately lead to contraction of the corpus cavernosum smooth muscle. 23 Karkanis et al. 24 used the patch-clamp technique to demonstrate the presence of calcium-activated depolarizing currents in both rat and human corpus cavernosum myocytes. In addition, they undertook in vivo experiments on rats to determine the effects of intracavernosal administration of known chloride channel blockers. Inhibition of chloride channels produced dose-dependent increases in intracavernosal pressure in male rats. Ensuing investigations have demonstrated the importance of CaCCs in the control of corporeal tissue contraction through both isolated tissue experiments using rabbit corpus cavernosum, as well as through the effects of intracavernous injection of chloride channel and chloride transport blockers on intracavernosal pressure in male rats. 25, 26 Although CaCCs are known to be essential for noradrenaline-induced smooth muscle contraction, research suggests that the increases or decreases in activity of CaCCs may have a role in modulation of smooth muscle contraction through other signalling cascades.
The mechanism by which CaCCs affect smooth muscle contraction can be summarized into four key steps: (i) intracellular calcium levels increase, (ii) CaCCs open in response to the calcium increase, (iii) depolarization results as anions effuse from the cell and (iv) voltage-dependent calcium channels (VDCCs) on the plasma membrane open because of the change in voltage, allowing the large increase in calcium required for contraction. However, both the initiation and the inhibition of this signalling process can be affected by three different physiological pathways: stimulation by the sympathetic nervous system, spontaneous calcium release and inhibition through the erectrogenic nitric oxide (NO) pathway ( Figure 1 ).
Perhaps the most significant is the integral role played by CaCCs in producing smooth muscle contraction following sympathetic stimulation. Activation of alpha-1 adrenoreceptors by noradrenaline leads to the intracellular release of calcium from the sarcoplasmic reticulum thereby activating the CaCCs and leading to the contraction of corpus cavernosum smooth muscle. Continuous activation by noradrenaline is one mechanism that has long been implicated in the constant smooth muscle tone required to maintain flaccidity, and may also have a role in detumescence during the termination of erections. 27 Interestingly, increased alpha-adrenoceptor sensitivity in the penis has been correlated with age and although activity of CaCCs has not been examined in aged individuals, an increase in CaCC activity may contribute to the higher rates of ED in older populations. 28 
Table 1. Families of chloride channels

Family
Members Description
Ligandgated
GABA and glycine receptors These channels act as receptors for two inhibitory neurotransmitters---GABA and glycine. Activation of these channels by ligand binding allows a chloride current (generally an inward, hyperpolarizing current), thereby preventing the action potential required for post-synaptic activation. CFTR Cystic fibrosis transmembrane regulator
The cystic fibrosis transmembrane regulator is a chloride channel that opens in response to ATP and contributes epithelial secretions through an efflux of Cl --.
ClC
Voltage-gated chloride channels These chloride channels (ClC-1 through ClC-9) are structurally similar and voltage gated. The functions, locations and mechanisms are diverse. Some of these channels are actually antiporters. VRAC Volume-or swelling-activated chloride channels
VRACs are activated when the volume of a cell increases and thereby have a role in homeostasis.
CaCC Calcium-activated chloride channels CaCCs are present in many different types of cells. They appear to have a role in epithelial secretion, olfactory transduction, as well as excitation of myocytes and neurons.
Abbreviations: ATP, adenosine triphosphate; CaCC, calcium-activated chloride channel; CFTR, cystic fibrosis transmembrane regulator; GABA, g-aminobutyric acid; VRAC, volume-regulated anion channel.
Another process by which intracellular calcium may be released leading to activation of CaCCs is the spontaneous release of calcium from intracellular stores in the form of 'sparks', or 'waves'. 29--31 The electrical activity resulting from these spontaneous releases of calcium may also contribute to the resting tonic contraction of the corpus cavernosum. 32 It is also important to note that parasympathetic stimulation of corpus cavernosum tissue by nitrergic nerves and endothelialderived NO produces erections and inhibition of chloride channels may have a crucial role in this process. 33 The NO/cyclic guanosine monophosphate (cGMP) pathway leads to the activation of a cGMP-dependent kinase I (also known as protein kinase G). This kinase promotes relaxation through several different actions: desensitization to calcium, the activation of large conductance potassium channels (BK) and the inhibition of calcium release from the sarcoplasmic reticulum. 34 The latter two actions of a cGMP-dependent kinase I both have an effect on intracellular calcium and, by extension, could be responsible for the effect on CaCCs. However, BK channels are also sensitive to calcium activation, so the net effect on BK channels is somewhat ambiguous. The activation of BK channels leads to an efflux of potassium ions, which hyperpolarizes the cell membrane, thereby making it less likely that VDCCs will open and produce muscle contraction. Although CaCC-mediated depolarization is important to facilitate the opening of VDCCs, VDCCs and CaCCs are involved in positive feedback and the opening of VDCCs may be essential to propagate the depolarization of the membrane. 29 Perhaps even more significantly, the inhibition of intracellular calcium release affects a key step leading to chloride channel activation, and could promote relaxation of the corpus cavernosum by interfering with the contractile tone dependent on CaCCs. It has also been demonstrated that vascular smooth muscle exhibits a non-classical CaCC that is dependent on cGMP. 35, 36 On the contrary, recent data show that cGMP was capable of inhibiting chloride efflux during noradrenaline-induced contraction response in the corpus cavernosum. 37 CaCCs are of vital importance to erectile function, but investigations into mechanisms and roles of CaCCs have been hampered by not knowing the molecular identity of CaCCs and the absence of any selective inhibitors of CaCCs. 10, 20, 38, 39 However, recent efforts have led to discoveries that may remedy both of these challenges.
ADVANCES IN THE IDENTIFICATION OF THE MOLECULAR IDENTITY OF CACCS
Although chloride currents characteristic of CaCCs were first described almost 30 years ago, efforts to elucidate the specific cellular component responsible have proven problematic. The identification of the molecular identity of classical CaCCs has undergone constant evolution. Two different proposed identities (CLCA and bestrophin proteins) emerged and subsequently fell out of favor as a new, more promising identity (the anoctamin protein family) came to prominence in 2008. However, research published in 2011 suggests that anoctamins may not be the sole molecular structure responsible for classical calcium-activated chloride currents, and are even not the principal type of CaCC in certain epithelial tissues, which leaves the question of the identity of CaCCs open. 40 
CLCA
An early candidate for the CaCC was the CLCA gene, which was identified through antibody screening and found to produce calcium-sensitive chloride currents when expressed in bovine tracheal epithelia. 41 Despite exerting some important regulatory effects on CaCCs, the CLCA proteins have biophysical properties, Figure 1 . CaCCs and signalling pathways in corpus cavernosum. CaCC activity is likely modified by several signalling pathways. Some of the signalling pathways that have been implicated in modulating the activity of CaCCs are shown. NA released by nerves of the sympathetic nervous system binds to a 1 adrenoceptors (a), producing increases in IP 3 (b), which in turn promote intracellular calcium release (c). Intracellular calcium is released (1), binds to calmodulin (2) and this complex increases anion efflux through CaCC (3). The depolarization of the membrane (4) activates VDCC, allowing the Ca 2 þ influx (5) necessary for muscle contraction. NO released from parasympathetic nerves and vascular endothelium during sexual arousal stimulates guanylyl cyclase (I); the activated guanylyl cyclase converts GTP to cGMP (II). PKG is activated by cGMP (III), and alters several products through phosphorylation resulting in inhibition of Ca 2 þ release from the sarcoplasmic reticulum (IV) and activation of BK channels (V). The resulting Ca 2 þ release and hyperpolarization of the membrane (VI) inhibit contraction. a 1 , alpha-1 receptor; BK, large-conductance potassium channel; CaCC, calcium-activated chloride channel; cGMP, cyclic guanosine monophosphate; Gq, Gq heteromeric protein; GTP, guanosine triphosphate; IP 3 , inositol triphosphate; NA, noradrenaline; NO, nitric oxide; PKG, protein kinase G; VDCC, voltage-dependent calcium channel.
such as pharmacology, calcium sensitivity, voltage sensitivity and pattern of expression, which were inconsistent with classical CaCCs. 20, 38, 42, 43 
BESTROPHINS
In the early 2000s, proteins known as bestrophins were found by several studies to be chloride channels. 38, 44 Further studies using heterologous expression, structural analysis, RNA interference knock-down, as well as comparison of some functional properties suggested that bestrophins formed CaCCs or at least a required subunit of the molecular CaCCs. 45--48 However, owing to evidence that wild-type bestrophins exhibit neither the voltage dependence nor outward rectification of CaCCs, 20 the theory that bestrophins are classical CaCCs has recently fallen out of favor. 49, 50 It was suggested that bestrophins may actually be regulators of calcium channels. 51 There is also promising evidence based on patch-clamp investigations that bestrophins are responsible for the non-classical cGMP-dependent calcium-activated chloride currents in vascular smooth muscle cells. 52 
ANOCTAMINS
Three studies with different methodologies performed by separate research groups in 2008 identified transmembrane protein 16A (also known as TMEM16A, anoctamin-1 and ANO1) as a CaCC. 53--55 This led to the current theory that suggests CaCCs are formed by TMEM16A and other members of the TMEM16 family of ten transmembrane proteins---recently dubbed 'anoctamin-1 through anoctamin-10'. 55 This theory is supported by considerable experimental evidence and has been expertly summarized as part of a review of chloride channels by Duran et al. 2 Studies have demonstrated that anoctamins produce calcium-triggered chloride currents when heterologously expressed, 53, 55 and exhibit properties very similar to those of classical CaCCs. 2 The theory that additional subunits are required for CaCCs or, alternatively, indirect pathways of calcium activation are utilized (such as binding with calmodulin) has been suggested because of structural evidence that anoctamins lack a calcium-binding domain. 56 A recently published study also indicates that the anoctamin-1 protein associates with calmodulin, although the authors were unable to show precisely how this interaction occurs. 57 However, the history of misidentifying CaCCs may be continuing. It has been frequently noted that it is possible that anoctamins do not form the entire chloride channel alone, and the anoctamin component may be a subunit of a larger channel assembly for CaCCs. 3, 53, 58 Another group identified several specific, smallmolecule inhibitors of anoctamin-1, however, these inhibitors not only failed to prevent a calcium-activated chloride current in intestinal and pulmonary epithelial cells, but knock-down of anoctamin-1 expression with small interfering RNA also had no effect on CaCCs. 40 It is important to note, however, that calciumactivated chloride current in salivary gland epithelial cells was completely abolished by the same inhibitors and small interfering RNA. 40 Also, another similar study successfully blocked calciumactivated chloride currents in pulmonary arterial smooth muscle cells. 59 Despite the fact that anoctamins are by far the most promising of all molecular candidates to date, the history of incorrectly identifying molecules as CaCCs should serve as a reminder to be cautious about embracing these proteins as the true answer to the elusive identity of CaCCs in smooth muscle cells.
PHARMACOLOGY
It has been proposed that inhibitors and activators of CaCC activity could prove to be therapeutically valuable for the treatment of many different disorders other than refractory ED, 25 including: cystic fibrosis, 60 asthma, 61 hypertension, 53 secretory diarrhea and even as a cancer treatment. 49 Despite this enormous potential, the pharmacological 'toolkit' for CaCCs has, until recently, consisted of only a few poorly selective chloride channel inhibitors and activators, and it has been frequently noted that effective, selective inhibitors could be invaluable to researchers investigating the physiology of these ion channels. 10, 20, 38, 39 Some well-characterized inhibitors of chloride channel activity include 5-nitro-2-(3-phenylpropylamino) benzoic acid, 4,4 0 -diisothiocyanatostilbene-2,2 0 -disulphonic acid, niflumic acid, mefloquine, tamoxifen and n-phenyl-anthranilic acid; all of which have also been demonstrated to inhibit anoctamin-1. 55 These compounds do not, however, show very much specificity for CaCCs: many of them are active on other families of chloride channels (often CFTR and volume-regulated anion channels), and some also have activity on non-chloride ion channels. 10 For example, many of the chloride channel blockers also act as activators of calciumactivated potassium channels. These drugs (particularly the fenamates such as niflumic acid) are often used in experiments despite the fact that it can be difficult to determine whether effects should be attributed to the block of CaCCs or activation of calcium-activated potassium channels; a challenge that has been discussed in detail by Greenwood and Leblanc. 62 In the past few years, efforts to identify CaCC-modifying compounds have begun to come to fruition. CaCC modulators currently in development include denufosol and lancovutide (also called duramycin), both of which are CaCC activators undergoing clinical trials for the treatment of cystic fibrosis. 3, 59 However, neither denufosol nor lancovutide act directly to activate CaCCs. It is believed that CaCC activity is increased through the activation of purinergic receptors or an increase in intracellular calcium, respectively. 60 As activators of chloride channels these compounds could be expected to be inhibitory to erections and only potentially have clinical benefit to less common disorders such as priapism.
Another CaCC modulator currently under development is crofelemer, a compound originally discovered as a component of the bark latex of Croton lechleri used by indigenous South Americans as a remedy for a variety of diseases. 63, 64 Crofelemer acts not only as an inhibitor at CaCCs (and has been confirmed to inhibit anoctamin-1) but also as a partial antagonist at CFTR channels. 64 Inhibition of CaCCs and CFTR reduces chloride and fluid secretion from the intestinal epithelia, 64 and could be valuable in the treatment of secretory diarrheas. 65 Phase III clinical trials on crofelemer were recently completed with positive results, but it has not been evaluated for activity on smooth muscle cells. Crofelemer is not absorbed, so oral crofelemer is unlikely be useful as a potential treatment for ED.
The development of specific laboratory techniques (even before the identification of the putative molecular identity of the channels) has facilitated significant advances. A recent review discussed useful techniques (among other topics) in considerable detail and the technology will not be discussed in detail here. 3 As mentioned above, a very recent study discovered a few specific inhibitors of anoctamin-1. 40 However, several other papers have also recently performed successful screens for CaCC inhibitors. Using high-throughput screening, De La Fuente et al. 66 recently identified six novel classes of compounds (from a screen of 50 000 compounds) with inhibitory activity on intestinal epithelial CaCCs. These classes were designated as classes A through F. Classes A and B were specifically found to be likely to act directly on the CaCCs, as opposed to any subcellular signalling processes. The most potent inhibitors of the two direct inhibitor classes were 'CaCC inh -A01' (from 'class A', the 3-acyl-2-aminothiophen class) and 'CaCC inh -B01' (from 'class B', the 5-aryl-2-aminothiazole class). Both of these compounds appear to have selectivity toward CaCC receptors, and CaCC inh -A01 has been used in other studies as a tool for blocking CaCCs. 67 A few other compounds have been shown to have activity on CaCCs. Liang et al. 68 performed a high-throughput screen of a drug library and found that spiperone, a psychoactive drug, could elicit the release of calcium ions from the sarcoplasmic reticulum, and activate CaCCs. A different study performed by Namkung et al. 69 found that gallotannins (natural antioxidant compounds that are found in green tea and red wine) could inhibit anoctamin-1 chloride conduction in cultured epithelial cells and prevent contraction of rat arterial smooth muscle cells. Although these are just small preliminary studies, they clearly illustrate not only the growing interest in CaCC-targeted therapeutics but the success of new screening methods at isolating compounds with specific inhibitory activity.
AREAS FOR FUTURE WORK
The importance of chloride channels in the corpus cavernosum has been clearly demonstrated, but there are many directions for future research to advance our understanding of these ion channels and move toward the development of new chloride channel-targeted therapeutics for ED. A quantitative PCR expression study performed by Schreiber et al. 58 indicated that various proteins of the anoctamin family are expressed in all murine tissues, with predominantly anoctamin-5 being primarily expressed in skeletal muscle, but there was little focus on smooth muscle and no mention of corpus cavernosum tissue. One next step could be performing expression studies to confirm the expression of anoctamin-1---or perhaps other members of the anoctamin family---in corpus cavernosum tissue.
Another potential avenue for research is the genetic manipulation of the proposed genes encoded CaCCs. The anoctamin-1 knockout mouse model by Rock et al. 70 suffered from tracheomalacia and died within a month after birth, but the RNA interference knockdown of anoctamin-1 successfully inhibited CaCCs in salivary gland epithelial cells. 40 Similar techniques may help elucidate the role of anoctamin-1 in corpus cavernosum tissue and other smooth muscle cell. Knockout of other anoctamin proteins may also prove informative as there is currently little information regarding the role that these proteins have.
There is also a considerable potential for future exploration from a pharmacological standpoint. The several recent successes in identifying small molecule inhibitors of CaCCs specifically holds a great deal of promise, but these compounds and many other compounds with activity on epithelial CaCCs have not yet been assessed for activity on smooth muscle cells. Electrophysiological studies of myocytes, as well as isolated tissue studies could be very informative about the selectivity and the therapeutic promise of these compounds in the field of sexual medicine. Inhibition of CaCCs may also prove to account for some of the therapeutic benefit of natural compounds as well. Specifically, antioxidants belonging to the gallotannin family, which are also CaCC inhibitors, 69 have previously been shown to be beneficial in the treatment of ED in artherosclerotic animal models. 71, 72 This in vivo study on antioxidants focused on preventing oxidative stress in the penis, but perhaps further investigation into this area will provide insight about whether direct chloride channel modulation also contributes to the antioxidants' effects at promoting erection.
It may also prove to be valuable to examine the role of CaCC inhibition for producing erections in different pathological models for ED. Using chloride channel inhibitors in animal models for aging, diabetes and hypertension could be the basis for identifying whether inhibition of CaCCs is therapeutically useful in treating ED.
CONCLUSION
Chloride channels are ubiquitously expressed in mammalian tissue and perform many essential, yet diverse roles. In the context of sexual medicine, modulation of the CaCC family of channels occurs both by chloride current activation through sympathetic stimulation, and inhibition through the parasympathetic NO/ cGMP pathway. Inhibition of CaCCs by pharmacological agents could theoretically be very valuable to the treatment of ED because, unlike current treatment with PDE5 inhibitors, the relaxation produced would not be dependent on NO signalling. Despite the potential of chloride channel modulators as therapeutics for ED and countless other diseases, chloride channel inhibitors have historically been plagued by very poor specificity, and, until recently, little has been known about the identity of the CaCCs themselves. The recent identification of a very promising candidate (the anoctamin family), and deliberate efforts to screen for specific chloride channel modulators have produced promising results. However, many of these studies focused on epithelial chloride channels and not the smooth muscle cell chloride channels such as those in the corpus cavernosum. In the future, research may confirm the identity of chloride channels in smooth muscle and discern whether compounds active on CaCCs in epithelial cells or arterial smooth muscle cells also have activity on CaCCs in the smooth muscle of the corpus cavernosum.
